Market Cap 16.33M
Revenue (ttm) 0.00
Net Income (ttm) -96.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 20,300
Avg Vol 25,168
Day's Range N/A - N/A
Shares Out 3.94M
Stochastic %K 52%
Beta 3.01
Analysts Hold
Price Target $4.00

Company Profile

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as M3 Biotechnology, Inc. and changed...

Industry: Biotechnology
Sector: Healthcare
Phone: 425 620 8501
Address:
18706 North Creek Parkway, Suite 104, Bothell, United States
Vikingsstrade
Vikingsstrade Oct. 3 at 5:33 PM
$VOR $BIAF $ECDA $ATHA Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:46 PM
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:17 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $ATHA $SQNS $VCIG $REX
0 · Reply
AtlasFrontier
AtlasFrontier Sep. 24 at 3:37 AM
XPON is setting up to be next 400-500%+ runner, strong close after hours! Don't be late bulls! ✅Small float ✅NO Dilution Worry! ✅Golden cross on the daily ✅Double digit potentia, Lithium is heating up as the next massive market theme. ✅Chart is looking explosive. Watching $ATHA $MOB $TURB $ONDS
0 · Reply
DARKP00L
DARKP00L Sep. 23 at 8:36 PM
$ATHA 16:00 on Sep. 23 2025 Athira Pharma Has Been Granted A U.S. Patent "Methods of treating neurodegenerative disease (including dementia, Alzheimer's disease, and Parkinson's disease) with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues". https://t.co/NSHLVnfwcm. #tradeideas
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 23 at 7:57 PM
$ATHA patent headline into the close here.
0 · Reply
PatentGrants
PatentGrants Sep. 23 at 7:57 PM
$ATHA Athira Pharma has been granted a US patent "Methods of treating neurodegenerative disease (including dementia, Alzheimer's disease, and Parkinson's disease) with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues". https://ppubs.uspto.gov/pubwebapp/external.html?q=(12421276).pn.
0 · Reply
11thestate
11thestate Sep. 22 at 10:44 AM
$ATHA is accepting claims for a $10M settlement to resolve allegations it misled investors about research integrity, including claims that its former CEO altered images in scientific papers to inflate stock credibility. Even if you missed the deadline, if you bought $ATHA between September 17, 2020, and June 17, 2021, you still can file for payment here: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09222025_1
0 · Reply
TwongStocks
TwongStocks Sep. 18 at 8:13 PM
Today's reverse split results. Both closed green: $ATHA 1 for 10 Previous close $0.378, $3.78 split-adjusted Intraday high $4.05 Today's close $3.83 🟢Up 1.32% $ECDA 1 for 40 Previous close $0.0979, $3.916 split-adjusted Intraday high $4.76 Today's close $4.32 🟢Up 10.32%
0 · Reply
TwongStocks
TwongStocks Sep. 18 at 11:37 AM
$ATHA $ECDA Both with reverse splits today. Trading will resume at 9:00a ET with the RS in effect. RS details in the quoted post.
0 · Reply
Latest News on ATHA
Athira Pharma Announces Reverse Stock Split

Sep 11, 2025, 9:00 AM EDT - 23 days ago

Athira Pharma Announces Reverse Stock Split


Athira Pharma to Participate in Upcoming June Conferences

May 29, 2024, 7:00 AM EDT - 1 year ago

Athira Pharma to Participate in Upcoming June Conferences


Athira Pharma to Participate in Upcoming May Conferences

May 2, 2024, 7:00 AM EDT - 1 year ago

Athira Pharma to Participate in Upcoming May Conferences


Athira Pharma Provides 2023 Pipeline Outlook

Jan 5, 2023, 7:00 AM EST - 2 years ago

Athira Pharma Provides 2023 Pipeline Outlook


Vikingsstrade
Vikingsstrade Oct. 3 at 5:33 PM
$VOR $BIAF $ECDA $ATHA Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:46 PM
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:17 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $ATHA $SQNS $VCIG $REX
0 · Reply
AtlasFrontier
AtlasFrontier Sep. 24 at 3:37 AM
XPON is setting up to be next 400-500%+ runner, strong close after hours! Don't be late bulls! ✅Small float ✅NO Dilution Worry! ✅Golden cross on the daily ✅Double digit potentia, Lithium is heating up as the next massive market theme. ✅Chart is looking explosive. Watching $ATHA $MOB $TURB $ONDS
0 · Reply
DARKP00L
DARKP00L Sep. 23 at 8:36 PM
$ATHA 16:00 on Sep. 23 2025 Athira Pharma Has Been Granted A U.S. Patent "Methods of treating neurodegenerative disease (including dementia, Alzheimer's disease, and Parkinson's disease) with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues". https://t.co/NSHLVnfwcm. #tradeideas
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 23 at 7:57 PM
$ATHA patent headline into the close here.
0 · Reply
PatentGrants
PatentGrants Sep. 23 at 7:57 PM
$ATHA Athira Pharma has been granted a US patent "Methods of treating neurodegenerative disease (including dementia, Alzheimer's disease, and Parkinson's disease) with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues". https://ppubs.uspto.gov/pubwebapp/external.html?q=(12421276).pn.
0 · Reply
11thestate
11thestate Sep. 22 at 10:44 AM
$ATHA is accepting claims for a $10M settlement to resolve allegations it misled investors about research integrity, including claims that its former CEO altered images in scientific papers to inflate stock credibility. Even if you missed the deadline, if you bought $ATHA between September 17, 2020, and June 17, 2021, you still can file for payment here: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09222025_1
0 · Reply
TwongStocks
TwongStocks Sep. 18 at 8:13 PM
Today's reverse split results. Both closed green: $ATHA 1 for 10 Previous close $0.378, $3.78 split-adjusted Intraday high $4.05 Today's close $3.83 🟢Up 1.32% $ECDA 1 for 40 Previous close $0.0979, $3.916 split-adjusted Intraday high $4.76 Today's close $4.32 🟢Up 10.32%
0 · Reply
TwongStocks
TwongStocks Sep. 18 at 11:37 AM
$ATHA $ECDA Both with reverse splits today. Trading will resume at 9:00a ET with the RS in effect. RS details in the quoted post.
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Sep. 18 at 7:29 AM
$ATHA ** Athira Pharma (ATHA) is undergoing a reverse stock split today, September 18, 2025. The split is at a 1-for-10 ratio. Previous Shares Outstanding: ~39.44 million ​Reverse Split Ratio: 1-for-10 ​New Estimated Shares Outstanding: ~3.94 million.
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Sep. 18 at 2:36 AM
🌞🌞 watchlist part 2 ✅️ $NFE mid 2.50 support, if above 3, have potential to 3.40/.50 ✅️ $ECDA 1/40 reverse split, new price ~ 4 ✅️ $ATHA 1/10 reverse split, new price ~ 3.80 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if below current support 🚫🚫 Avoid chasing long into strength near resistance ✅️ $TBH $OTRK still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
0 · Reply
TwongStocks
TwongStocks Sep. 17 at 8:54 PM
I am aware of two NASDAQ reverse splits on Thursday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Thursday morning. $ATHA 1 for 10. Will reduce outstanding shares from approx 39.44m to approx 3.94m. $ECDA 1 for 40. Will reduce outstanding shares from approx 59.09m to approx 1.48m.
0 · Reply
TwongStocks
TwongStocks Sep. 16 at 8:11 PM
$ATHA NASDAQ Equity Corporate Actions Alert # 2025 - 509 Information Regarding the Reverse Stock Split and CUSIP Number Change for Athira Pharma, Inc. (ATHA) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-509 Athira Pharma, Inc. (ATHA) will effect a one-for-ten (1-10) reverse split of its Common Stock. The reverse stock split will become effective on Thursday, September 18, 2025. In conjunction with the reverse split, the CUSIP number will change to 04746L203.
0 · Reply
11thestate
11thestate Sep. 9 at 1:42 PM
Losses on $ATHA? Time to take action. See what’s happening: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09092025_1 #ATHA
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 6:25 AM
$ATHA Excellent article that nails exactly where ATHA stands right now. So if you want to update your ATHA knowledge or get acquainted with ATHA, this is a must read. https://beyondspx.com/quote/ATHA/athira-pharma-a-bold-strategic-shift-towards-als-with-hgf-met-innovation-nasdaq-atha#analysis
0 · Reply
11thestate
11thestate Aug. 29 at 1:14 PM
That’s the most useful info you’ve seen on $ATHA in years. https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08292025_1 #Athira #ATHA
0 · Reply
DARKP00L
DARKP00L Aug. 25 at 4:37 PM
$ATHA this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
BigSqueezeComing
BigSqueezeComing Aug. 25 at 8:39 AM
$ATHA pm gappers
0 · Reply
SignalPath
SignalPath Aug. 23 at 6:12 AM
$ATHA Athira Pharma is developing Alzheimer's treatments with novel mechanism and clinical risk
0 · Reply
11thestate
11thestate Aug. 21 at 3:20 AM
Losses on $ATHA aren’t the end of the story. Find out how to recover: https://11th.com/cases/purecycle-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08212025_1 #ATHA
0 · Reply
11thestate
11thestate Aug. 13 at 11:15 AM
$ATHA has agreed to a $10 million settlement with investors to resolve claims that the company misled them regarding research integrity. Who’s eligible? Anyone who bought and held $ATHA stock between September 17, 2020, and June 17, 2021. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold your shares. How much is the payout? The payout per share is $0.47 — but if only ~25% of eligible investors file, the effective payout could increase to $1.88 per share. Can I still file? Yes — late claims are currently being considered, pending court approval. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/athira-ipo-spo-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=08122025_1
0 · Reply